Today, Darren Sissons commented about whether AUKNY-OTC, ACO.X-T, ACN-N, ZM-Q, TSM-N, WDC-Q, IBM-N, TRZ-T, COST-Q, VOD-Q, MURGF-OTC, BP-N, TSLA-Q, JPM-N, PYPL-Q, SQ-N, LSPD-T, BB-T, PFE-N, ABT-N, BA-N, AMLP-N are stocks to buy or sell.
ABT-N vs. PFE-N. Abbot Labs has a Great franchise. Very well loved by the investment community. You are really not getting any opportunity to invest at a cheaper valuation. PFE-N is somewhat of a drug ETF. They have a big portfolio. You are bidding on their strategy of buying and selling drug lines. This one will be well positioned. The entry price is not the greatest but you could buy it and you would be fine.
ABT-N vs. PFE-N. Abbot Labs has a Great franchise. Very well loved by the investment community. You are really not getting any opportunity to invest at a cheaper valuation. PFE-N is somewhat of a drug ETF. They have a big portfolio. You are bidding on their strategy of buying and selling drug lines. This one will be well positioned. The entry price is not the greatest but you could buy it and you would be fine.
He believes there are better opportunities. OTEX-T is a more interesting company. If you have made money then it is time to move on.
SQ-N vs. PYPL-Q. The broader payment processing space is great but he prefers V-N. These are expensive stocks. PYPL-Q has abroad offering so probably the better one to buy. He would say that you should look at the best-of-breed, V-N. Paypal would be the preference between the two, however.